Related Experiment Videos
Genetic profile of gliosarcomas
R M Reis1, D Könü-Lebleblicioglu, J M Lopes
1International Agency for Research on Cancer, Lyon, France.
The American Journal of Pathology
|February 10, 2000
Summary
Gliosarcomas, a rare brain tumor variant, share genetic similarities with primary glioblastomas but lack epidermal growth factor receptor amplification. This suggests a monoclonal origin and mesenchymal differentiation from a common precursor.
Area of Science:
- Neuro-oncology
- Cancer Genetics
- Molecular Pathology
Background:
- Glioblastoma, the most malignant brain tumor, arises through distinct genetic pathways.
- Primary glioblastomas (older patients) feature EGFR amplification, p16 deletion, and PTEN mutations.
- Secondary glioblastomas (younger patients) often have p53 mutations.
Purpose of the Study:
- To investigate the genetic profile of gliosarcoma, a rare glioblastoma variant.
- To compare the genetic alterations in gliosarcoma to those in primary and secondary glioblastomas.
- To explore the cellular origin and differentiation of gliosarcoma.
Main Methods:
- Single-strand conformation polymorphism and DNA sequencing for p53 and PTEN mutations.
- Differential polymerase chain reaction for homozygous p16 deletion.
- Analysis of Rb pathway alterations (p16 deletion, CDK4 amplification, pRb loss).
Main Results:
- p53 mutations in 26% and PTEN mutations in 37% of gliosarcomas.
- Homozygous p16 deletion in 37% of gliosarcomas; 53% showed Rb pathway alterations.
- Absence of epidermal growth factor receptor (EGFR) amplification/overexpression in all gliosarcomas.
- Identical mutations (PTEN, p53) and genetic alterations (p16 deletion, MDM2/CDK4 coamplification) found in both glial and sarcomatous components.
Conclusions:
- Gliosarcomas resemble primary glioblastomas genetically, except for EGFR status.
- Findings support a monoclonal origin for gliosarcomas.
- The sarcomatous component likely arises from aberrant mesenchymal differentiation of a malignant astrocytic neoplasm.